Fingerprint
Dive into the research topics of 'A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically